ISR IMMUNE SYS.REGUL.

Share · SE0008212195 · A2AGDK (XSTO)

Overview

No Price

n/a

Share Float & Liquidity

Free Float -

Shares Float -

Shares Outstanding 69,01 M

Company Profile for ISR IMMUNE SYS.REGUL. Share

ISR Immune System Regulation Holding AB (publ) researches and develops drugs for the treatment of viral infections in Sweden. The company's product pipeline includes Covid-19 vaccine, HBV, HIV, and oncology. The company is headquartered in Stockholm, Sweden.

Get up to date insights from finAgent about ISR IMMUNE SYS.REGUL.

Company Data

Name ISR IMMUNE SYS.REGUL.

Company ISR Immune System Regulation Holding AB (publ)

Website https://israb.se

Primary Exchange

NASDAQ STOCKHOLM AB

WKN A2AGDK

ISIN SE0008212195

Asset Class Share

Sector Healthcare

Industry Biotechnology

CEO Ola S. Winqvist

Market Capitalization 97 Mio

Country Sweden

Currency SEK

Employees 0,0 T

Address Retzius vAeg 11, 171 65 Stockholm

IPO Date 2017-03-24

Ticker Symbols

Name	Symbol
NASDAQ STOCKHOLM AB	ISR.ST

More Shares

Investors who hold ISR IMMUNE SYS.REGUL. also have the following shares in their portfolio:

DB STRATEGIC INCME ALLOCATION EUR (SIA) BALANCED PLUS LBD Fund

NIBC BANK 24/35 FLR MTN Bond

The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.

Imprint Data Protection Blog Community Feedback Changelog